NCT03806140

Brief Summary

Investigators will test the feasibility and acceptability, as well as efficacy (exploratory aim) of a text messaging intervention for Adolescents and young adults (AYA) transitioning off active treatment for cancer. Texting Health Resources to Inform, motiVate, and Engage (THRIVE) is intended to improve knowledge about health promotion and health vulnerability and importance of continued engagement in care, while also providing support and improving efficacy to achieve health-related goals.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2014

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

January 10, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 16, 2019

Completed
Last Updated

January 16, 2019

Status Verified

January 1, 2019

Enrollment Period

1.5 years

First QC Date

January 10, 2019

Last Update Submit

January 14, 2019

Conditions

Keywords

TextingmHealthAdolescents and young adults transitioning of treatment

Outcome Measures

Primary Outcomes (3)

  • Acceptability of promoting a tailored text messaging intervention for AYA transitioning off active treatment

    All patients will complete a measure of acceptability at the outcome data collection-. The questionnaire consists of 27 items for the control group and 31 items for the intervention group. Items will be answered on a Likert-scale and one open-ended question intended to elicit suggestions for improving the intervention. Items pertain to perceived value, appropriateness, convenience and helpfulness of the intervention.

    16 weeks

  • Number of patients completed 16 week measures

    Completion of follow-up measures which will be logged by research team for feasibility

    16 weeks

  • Number of patient-reported barriers to technology of text messages

    Number of participants who report barriers or issues with the text messages and technology for feasibility

    16 weeks

Secondary Outcomes (11)

  • Health competence beliefs

    16 weeks

  • Engagement in health promoting behaviors

    16 weeks

  • Changes in health competence beliefs

    16 weeks

  • Changes in health related quality of life (HRQL) in adolescent and young adult survivors of childhood cancer

    16 weeks

  • Patient adherence to clinic attendance

    16 weeks

  • +6 more secondary outcomes

Study Arms (2)

Intervention group

ACTIVE COMPARATOR

Receive daily text messages

Behavioral: text messages

Control group

NO INTERVENTION

No text messages, only written educational materials

Interventions

text messagesBEHAVIORAL

receive about one health-related text message a day for 16 weeks

Intervention group

Eligibility Criteria

Age12 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosed with cancer
  • Males or females between the ages of 12 and 25
  • In remission (per documentation in chart)
  • Within 12 months of completing active treatment for cancer
  • Cognitively capable to complete measures (per documentation in chart of impairment or parent or provider report).
  • Able to read and speak English.
  • Parent available to provide consent for those ages 12 to 17

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Lisa Schwartz, PhD

    Children's Hospital of Philadelphia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 10, 2019

First Posted

January 16, 2019

Study Start

July 1, 2014

Primary Completion

January 1, 2016

Study Completion

January 1, 2016

Last Updated

January 16, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share